|
|
 |
|
Viewing report
|
|
|
|
Osteoporosis Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc, Jan 2011, Pages: 434
This report analyzes the worldwide markets for Osteoporosis Therapeutics in US$ Million by the following major therapeutic classes: Bisphosphonates, ERT Drugs, SERMs, Calcitonins, and MAB (Denosumab). The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets.
The report profiles 51 companies including many key and niche players such as
- Abbott Laboratories (US)
- Eli Lilly and Company (US)
- F.Hoffmann-La Roche Ltd (Switzerland)
- Merck & Co., Inc. (US)
- Novartis AG (Switzerland)
- Novo Nordisk A/S (Denmark)
- Pfizer, Inc. (US)
- Wyeth (US)
- Sanofi-Aventis SA (France)
- Servier SA (France)
- Unigene Laboratories, Inc. (US)
- Warner Chilcott plc (Ireland)
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
|
|
|
|
